Endpoints News 2026년 3월 20일 Sarepta to ask FDA for full approval of exon skipping drugs; Rhythm's label expansion in rare form of obesity
Endpoints News 2026년 3월 20일 UK’s NICE revisits Lilly, Eisai Alzheimer's drugs under new pricing threshold
Endpoints News 2026년 3월 20일 Novartis to pay $2B upfront to take next-gen PI3Kα inhibitor from Synnovation
Endpoints News 2026년 3월 20일 Genentech culls muscle-preserving drug in genetic diseases, raising questions about obesity trial
Endpoints News 2026년 3월 20일 Turmoil at ACIP continues after claim committee ‘disbanded’ is quickly refuted
Endpoints News 2026년 3월 19일 AstraZeneca deepens UK-China ties with cell therapy R&D hub, manufacturing plans